The ENACT Act

Wysiwyg

To ensure future treatments and means of prevention are effective in all populations, Alzheimer’s and other dementia research must be reflective of all Americans.To address this issue, AIM worked with bipartisan congressional champions to develop the ENACT Act in the 117th Congress. This important legislation was also supported by other stakeholders.

Key provisions of the bipartisan Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act, included in the Fiscal Year 2023 budget in December 2022, are advancing this goal. 

The ENACT Act is working to increase the participation of underrepresented populations in Alzheimer’s and other dementia clinical trials by expanding education and outreach to these populations, encouraging the diversity of clinical trial staff, and reducing participation burden, among other priorities. The underrepresentation of these populations not only hinders the ability of researchers to understand health disparities, it also restricts their knowledge of how an approved therapy or diagnostic may affect the populations most likely to need the treatment. Learn more about this bill from one of the lead sponsors, Rep. Blunt Rochester (D-Del.).

While we have much more yet to accomplish, we can join with our advocacy network to celebrate this significant progress that will help ensure that no one is left behind, especially communities most affected by Alzheimer’s and dementia.

celebratory advocates

Be a Champion in the Fight to End Alzheimer’s

Our voices are stronger together. Help AIM advance legislation to improve the lives of people impacted by Alzheimer’s and all other dementia.

  • Share your story with elected officials
  • Engage on social media
  • Write a letter to the editor

Federal Priorities

Our Nation’s Commitment to Alzheimer’s Research and Public Health Response

Congress must continue to invest in Alzheimer’s and dementia research at the National Institutes of Health (NIH), and fund the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (P.L. 115-406) to strengthen the public health infrastructure across the country by implementing effective Alzheimer’s intervention focused on public health issues such as increasing early detection and diagnosis, reducing risk, and preventing avoidable hospitalizations.